Ryan Zimmerman
Stock Analyst at BTIG
(4.00)
# 590
Out of 5,140 analysts
229
Total ratings
52.58%
Success rate
10.91%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PEN Penumbra | Downgrades: Neutral | $349 | $357.68 | -2.43% | 21 | Jan 16, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterates: Buy | $112 | $86.55 | +29.40% | 10 | Jan 8, 2026 | |
| ISRG Intuitive Surgical | Maintains: Buy | $589 → $616 | $523.69 | +17.63% | 22 | Jan 7, 2026 | |
| ENOV Enovis | Initiates: Buy | $41 | $23.68 | +73.14% | 1 | Jan 6, 2026 | |
| GKOS Glaukos | Reiterates: Buy | $116 | $124.16 | -6.57% | 15 | Jan 2, 2026 | |
| ORGO Organogenesis Holdings | Reiterates: Buy | $9 | $3.84 | +134.38% | 10 | Dec 26, 2025 | |
| CARL Carlsmed | Reiterates: Buy | $24 | $13.23 | +81.41% | 2 | Dec 15, 2025 | |
| RBOT Vicarious Surgical | Suspends: Neutral | n/a | $2.41 | - | 4 | Dec 12, 2025 | |
| SOLV Solventum | Upgrades: Buy | $100 | $80.37 | +24.42% | 2 | Dec 2, 2025 | |
| ALC Alcon | Reiterates: Buy | $91 | $81.62 | +11.49% | 13 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.98 | +512.24% | 6 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $87 | $81.10 | +7.27% | 4 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $3.89 | - | 4 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $410 | $362.94 | +12.97% | 18 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.5 → $3 | $1.54 | +94.81% | 2 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $1.5 | $0.63 | +138.10% | 3 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.61 | - | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 | $30.51 | -8.23% | 5 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $18.67 | +23.19% | 10 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $75.14 | - | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $195 | $163.65 | +19.16% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $37.72 | - | 9 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $30.95 | - | 2 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $14.39 | +59.83% | 1 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $148 | $120.73 | +22.59% | 7 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.95 | - | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $94.15 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $12.19 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $20.61 | +157.16% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $13.85 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $146.21 | +36.79% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $284.96 | +22.82% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $100.29 | +27.63% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $12.33 | +21.65% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $17.07 | +146.05% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $7.58 | +592.61% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $33.01 | - | 3 | Apr 2, 2020 |
Penumbra
Jan 16, 2026
Downgrades: Neutral
Price Target: $349
Current: $357.68
Upside: -2.43%
Zimmer Biomet Holdings
Jan 8, 2026
Reiterates: Buy
Price Target: $112
Current: $86.55
Upside: +29.40%
Intuitive Surgical
Jan 7, 2026
Maintains: Buy
Price Target: $589 → $616
Current: $523.69
Upside: +17.63%
Enovis
Jan 6, 2026
Initiates: Buy
Price Target: $41
Current: $23.68
Upside: +73.14%
Glaukos
Jan 2, 2026
Reiterates: Buy
Price Target: $116
Current: $124.16
Upside: -6.57%
Organogenesis Holdings
Dec 26, 2025
Reiterates: Buy
Price Target: $9
Current: $3.84
Upside: +134.38%
Carlsmed
Dec 15, 2025
Reiterates: Buy
Price Target: $24
Current: $13.23
Upside: +81.41%
Vicarious Surgical
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $2.41
Upside: -
Solventum
Dec 2, 2025
Upgrades: Buy
Price Target: $100
Current: $80.37
Upside: +24.42%
Alcon
Nov 24, 2025
Reiterates: Buy
Price Target: $91
Current: $81.62
Upside: +11.49%
Nov 21, 2025
Reiterates: Buy
Price Target: $6
Current: $0.98
Upside: +512.24%
Nov 21, 2025
Reiterates: Buy
Price Target: $87
Current: $81.10
Upside: +7.27%
Nov 20, 2025
Upgrades: Neutral
Price Target: n/a
Current: $3.89
Upside: -
Nov 14, 2025
Reiterates: Buy
Price Target: $410
Current: $362.94
Upside: +12.97%
Nov 12, 2025
Maintains: Buy
Price Target: $3.5 → $3
Current: $1.54
Upside: +94.81%
Nov 11, 2025
Maintains: Buy
Price Target: $2 → $1.5
Current: $0.63
Upside: +138.10%
Nov 7, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.61
Upside: -
Nov 4, 2025
Upgrades: Buy
Price Target: $28
Current: $30.51
Upside: -8.23%
Oct 29, 2025
Reiterates: Buy
Price Target: $23
Current: $18.67
Upside: +23.19%
Oct 21, 2025
Reiterates: Neutral
Price Target: n/a
Current: $75.14
Upside: -
Oct 13, 2025
Maintains: Buy
Price Target: $190 → $195
Current: $163.65
Upside: +19.16%
Sep 17, 2025
Downgrades: Neutral
Price Target: n/a
Current: $37.72
Upside: -
Sep 16, 2025
Reiterates: Neutral
Price Target: n/a
Current: $30.95
Upside: -
Sep 9, 2025
Reiterates: Buy
Price Target: $23
Current: $14.39
Upside: +59.83%
Jul 14, 2025
Maintains: Buy
Price Target: $145 → $148
Current: $120.73
Upside: +22.59%
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $9.95
Upside: -
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $94.15
Upside: -
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $12.19
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $20.61
Upside: +157.16%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $13.85
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $146.21
Upside: +36.79%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $284.96
Upside: +22.82%
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $100.29
Upside: +27.63%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $12.33
Upside: +21.65%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $17.07
Upside: +146.05%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $7.58
Upside: +592.61%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $33.01
Upside: -